The 2021 Genitourinary Cancers (GU) Symposium, held virtually, presented practice-changing data in the GU field and novel insights into burning questions, from Feb 11–13.
Leading experts from across the globe presented cutting-edge data, with a focus on translating this new evidence into multidisciplinary care. Explore the news here!
Watch @ErikaHamilton9 give a round-up of our upcoming post-#ASCO2021 Breast Cancer roundtable! 📆Wed 30-June at 6pm BST/1pm EDT/10am PDT 📆 Join Erika, @curijoey, @stolaney1 & Andrew Tutt as they cover the latest key breast cancer data! Register now 👉https://bit.ly/3wTS07P
⏰⏰⏰ 5 MINS ⏰⏰ ⏰ We're about to get started with the post-ASCO GU Cancer Session! It's not too late to join the discussion & learn from this amazing panel of leading experts! 👉http://tinyurl.com/GU-Cancer 👈 #ASCO2021 @ASCO @OncoAlert #UroOnc #BlcSM #kcsm #VJSessions
VIDEO: The IMMULAB trial: pembrolizumab with local ablation for patients with early-stage HCC w/ Arndt Vogel of the Hannover Medical School Watch now 👉http://ow.ly/381S50Ff8ME👈 @VJOncology @OncoAlert @ASCO #ASCO21 #HPBCsm #LiverCancer #Oncology #OncoAlert
🚨 1 hour warning! 🚨 Learn about adjuvant pembro, CLEAR & KN-426 in RCC, immunotherapy & enfortumab vedotin in bladder cancer and much more! DON'T MISS OUT! REGISTER NOW! http://tinyurl.com/GU-Cancer
Less than 3 hours until @ERPlimackMD, @tompowles1 & @DrRanaMcKay are going to be dissecting the key bladder & kidney data from #ASCO2021! Don't miss this fascinating roundtable at 6pm BST/1pm EDT/10am PDT Register now: http://tinyurl.com/GU-Cancer @ASCO @OncoAlert #VJSessions
The kidney cancer updates from the 2021 ASCO GU meeting are not to be missed.
Check out our latest updates!
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest oncology news and updates
Keep up to date with all the latest news with our monthly newsletter